REPL Stock Summary and Trading Ideas (Replimune Group | NASDAQ:REPL)

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

What symbol and exchange does Replimune Group shares trade?

Replimune Group trades on the NASDAQ stock market under the symbol REPL.

What is Replimune Group stock price doing today?

As of May 29, 2026, REPL stock price climbed to $8.69 with 36,392,252 million shares trading.

What is Replimune Group's Beta?

REPL has a beta of -5.11, meaning it tends to be less sensitive to market movements. REPL has a correlation of 0.07 to the broad based SPY ETF.

How much is Replimune Group worth?

REPL has a market cap of $681.67 million. This is considered a Small Cap stock.

How much money does Replimune Group make?

Last quarter Replimune Group reported $0 in Revenue and -$.77 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.06.

What is the highest and lowest price Replimune Group traded in the last 3 year period?

In the last 3 years, REPL traded as high as $24.81 and as low as $1.50.

What are the top ETFs holding Replimune Group?

The top ETF exchange traded funds that REPL belongs to (by Net Assets): XBI, IWM, VTI, IWN, IBB.

Is Replimune Group (REPL) a good investment?

REPL has underperformed the market in the last year with a return of +3.1%, while SPY returned +30.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in REPL shares. However, REPL has outperformed the market in the last 3 month and 2 week periods, returning +13.6% and +76.3%, while SPY returned +10.5% and +1.1%, respectively. This indicates REPL has been having a stronger performance recently.

What are the support and resistance levels for Replimune Group (REPL)?

REPL support price is $4.21 and resistance is $5.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that REPL shares will trade within this expected range on the day.